[HTML] from haematologica-thj.orgT Kamio, E Ito, A Ohara, Y Kosaka… - …, 2011 - haematologica-thj.org Results: From 1992 to 2007, we treated 441 children with aplastic anemia with standard immunosuppressive therapy. Among the 264 patients who responded to immunosuppressive therapy, 42 (15.9%) relapsed. The cumulative incidence of relapse was 11.9% at 10 years. Multivariate ... Cited by 1 - Related articles - All 12 versions
ML Webb, H Rosen, A Taghinia, ER McCarty… - The Journal of Hand …, 2011 - Elsevier PURPOSE: Fanconi anemia (FA) is a rare genetic disorder of DNA repair that with near uniformity leads to bone marrow failure and resulting morbidity and mortality. Approximately 50% of FA patients are born with anomalies of the thumb or thumb and radius, and it has ... Cited by 1 - Related articles - All 7 versions
GO Gbotosho, A Sowunmi, TM Okuboyejo… - The American journal of …, 2011 - ASTMH Abstract.: The therapeutic efficacy and effects of artemether-lumefantrine (AL) and artesunate-amodiaquine co-formulated (AAcf) or co-packaged (AAcp) on malaria-associated anemia (MAA) were evaluated in 285 children < 12 years of age with uncomplicated ... Cited by 4 - Related articles - All 3 versions
[PDF] from hindawi.comA Tenenbaum, S Malkiel, ID Wexler… - …, 2011 - downloads.hindawi.com Hindawi Publishing Corporation International Journal of Pediatrics Volume 2011, Article ID 813541, 5 pages doi:10.1155/2011/813541 ... Ariel Tenenbaum,1 Sarah Malkiel,1 Isaiah D. Wexler,1 Floris Levy-Khademi,1 Shoshana Revel-Vilk,2 and Polina Stepensky2 View as HTML
[HTML] from haematologica.itEB Shereck, RJ Deyell… - Haematologica, 2011 - haematologica.it Is there benefit from withholding treatment for non-severe AA until disease progression? One recent study of children with AA who received immunosuppressive treatment seems to suggest just that, showing a better response to immunosuppressive treatment in children with very ... Related articles - All 7 versions